Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, will host a conference call on Tuesday, August 9th, 2022, at 4:30 pm ET to report its financial results for the second quarter of 2022.
Conference Call & Webcast Details
Date: |
Tuesday, August 9th |
|
Time: |
4:30 pm Eastern Time |
|
Webcast: |
||
Toll Free: |
(800) 715-9871 |
|
International: |
(646) 307-1963 |
|
ID Number: |
303241 |
|
A live webcast of the conference call can be accessed in the Investors/ Media section of Infinity’s website at https://www.infi.com/ and will be available on Infinity's website for 30 days following the event.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220802005258/en/
Contacts
Irina Koffler
LifeSci Advisors, LLC
646-970-4681
ikoffler@lifesciadvisors.com
